BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9573303)

  • 1. Human immunodeficiency virus type 2 Vpx-Gag interaction.
    Pancio HA; Ratner L
    J Virol; 1998 Jun; 72(6):5271-5. PubMed ID: 9573303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular transport and virion incorporation of vpx requires interaction with other virus type-specific components.
    Kappes JC; Parkin JS; Conway JA; Kim J; Brouillette CG; Shaw GM; Hahn BH
    Virology; 1993 Mar; 193(1):222-33. PubMed ID: 8438567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein.
    Wu X; Conway JA; Kim J; Kappes JC
    J Virol; 1994 Oct; 68(10):6161-9. PubMed ID: 8083957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vpx proteins of SIVmac239 and HIV-2ROD interact with the cytoskeletal protein alpha-actinin 1.
    Mueller SM; Jung R; Weiler S; Lang SM
    J Gen Virol; 2004 Nov; 85(Pt 11):3291-3303. PubMed ID: 15483243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the nuclear localization signal of human immunodeficiency virus type 2 Vpx.
    Belshan M; Ratner L
    Virology; 2003 Jun; 311(1):7-15. PubMed ID: 12832198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-2 viral protein X association with the GAG p27 capsid protein.
    Horton R; Spearman P; Ratner L
    Virology; 1994 Mar; 199(2):453-7. PubMed ID: 8122374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV type 2 Vpx interaction with Gag and incorporation into virus-like particles.
    Jin L; Zhou Y; Ratner L
    AIDS Res Hum Retroviruses; 2001 Jan; 17(2):105-11. PubMed ID: 11177390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus type 2 vpx protein augments viral infectivity.
    Kappes JC; Conway JA; Lee SW; Shaw GM; Hahn BH
    Virology; 1991 Sep; 184(1):197-209. PubMed ID: 1714662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles.
    Wu X; Liu H; Xiao H; Conway JA; Kappes JC
    J Virol; 1996 Jun; 70(6):3378-84. PubMed ID: 8648668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction with the p6 domain of the gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentiviruses.
    Selig L; Pages JC; Tanchou V; Prévéral S; Berlioz-Torrent C; Liu LX; Erdtmann L; Darlix J; Benarous R; Benichou S
    J Virol; 1999 Jan; 73(1):592-600. PubMed ID: 9847364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of the simian immunodeficiency virus Vpx protein: identification of packaging determinants and a novel nuclear targeting domain.
    Mahalingam S; Van Tine B; Santiago ML; Gao F; Shaw GM; Hahn BH
    J Virol; 2001 Jan; 75(1):362-74. PubMed ID: 11119605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx.
    Wu X; Liu H; Xiao H; Kim J; Seshaiah P; Natsoulis G; Boeke JD; Hahn BH; Kappes JC
    J Virol; 1995 Jun; 69(6):3389-98. PubMed ID: 7745685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A conserved dileucine-containing motif in p6(gag) governs the particle association of Vpx and Vpr of simian immunodeficiency viruses SIV(mac) and SIV(agm).
    Accola MA; Bukovsky AA; Jones MS; Göttlinger HG
    J Virol; 1999 Dec; 73(12):9992-9. PubMed ID: 10559313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.
    Wu X; Liu H; Xiao H; Kappes JC
    Virology; 1996 May; 219(1):307-13. PubMed ID: 8623547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of SAMHD1 by Vpx Is Independent of Uncoating.
    Jáuregui P; Logue EC; Schultz ML; Fung S; Landau NR
    J Virol; 2015 May; 89(10):5701-13. PubMed ID: 25762741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of human immunodeficiency virus type 2 Vpx and invariant chain.
    Pancio HA; Vander Heyden N; Kosuri K; Cresswell P; Ratner L
    J Virol; 2000 Jul; 74(13):6168-72. PubMed ID: 10846101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus type 1 modified to package Simian immunodeficiency virus Vpx efficiently infects macrophages and dendritic cells.
    Sunseri N; O'Brien M; Bhardwaj N; Landau NR
    J Virol; 2011 Jul; 85(13):6263-74. PubMed ID: 21507971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 2 Vpx function in human myeloid cells.
    Goujon C; Arfi V; Pertel T; Luban J; Lienard J; Rigal D; Darlix JL; Cimarelli A
    J Virol; 2008 Dec; 82(24):12335-45. PubMed ID: 18829761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dispensable role of the human immunodeficiency virus type 2 Vpx protein in viral replication.
    Marcon L; Michaels F; Hattori N; Fargnoli K; Gallo RC; Franchini G
    J Virol; 1991 Jul; 65(7):3938-42. PubMed ID: 2041103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vpx association with mature core structures of HIV-2.
    Kewalramani VN; Emerman M
    Virology; 1996 Apr; 218(1):159-68. PubMed ID: 8615019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.